Please try another search
Horizon Discovery Group Limited operates as a cell engineering company and engages in the design, manufacture, and application of gene editing and gene modulation tools in the United Kingdom, the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company operates through screening, research reagents, diagnostics, and bioproduction segments. It provides custom-made and off-the-shelf (OTS) RNAi gene modulation reagents, CRISPR reagents, synthetic SGRNAs, OTS cell models, and custom cell engineering services. The company was founded in 2005 and is based in Cambridge, United Kingdom. As of December 23, 2020, Horizon Discovery Group Limited operates as a subsidiary of PerkinElmer (UK) Holdings Ltd.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review